Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
Clinical trial NCT03672292 · TERMINATED
Trial details
- NCT number
- NCT03672292
- Sponsor
- Scynexis, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2023-03-27
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.